Interestingly, it has recently been shown that RA patients treated with TNF-α-inhibiting biological therapies showed a 50% decreased risk of developing cognitive decline, where this may be due to the fact that TNF-α is involved in the physiopathology of dementia, as well as in that of RA [39]. Here, TNF is linked to rheumatoid arthritis.